tiprankstipranks

Orbimed Advisors Llc Insider Profile

32 Followers
Orbimed Advisors Llc, Shareholder at CTI BioPharma, holds 755.63K shares in Terns Pharmaceuticals (Ticker: TERN), holds 2.41M shares in TELA Bio (Ticker: TELA), holds 235.39K shares in Disc Medicine (Ticker: IRON). Most recently, Orbimed Advisors Llc Sold ― shares of Terns Pharmaceuticals on Jul 17, 2024 for an estimated value of 561.64K.
tipranks
Orbimed Advisors Llc

Orbimed Advisors Llc
CTI BioPharma (CTIC)
Shareholder

Ranked #4,718 out of 97,997 Corporate Insiders

Profitable Transactions

56%
111 out of 197 Profitable Transactions

Average Return

+4.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2B
15.94%
15.84%
10.57%
8.97%
48.68% Others
A breakdown of Orbimed Advisors Llc's holdings

Insider Roles

Edgewise Therapeutics
(EWTX)
Director, Ten Percent Owner
Insulet
(PODD)
Director
Springworks Therapeutics
(SWTX)
Ten Percent Owner
Enliven Therapeutics
(ELVN)
Director, Ten Percent Owner
+47 other positions
Roles that Orbimed Advisors Llc holds in companies

Most Profitable Insider Trade

Stock:
Sientra
(SIENQ)
Rating:Informative Buy
Date:Oct 28, 2014 - Oct 28, 2015
Return:+570.60%
The most profitable trade made by Orbimed Advisors Llc

Orbimed Advisors Llc's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
CTIC
CTI BioPharma
Jan 11, 2021
Informative Sell
7.00M
$68.36M
ICPT
Intercept Pharma
Jul 21, 2015
Uninformative Buy
$21.29M
Repare Therapeutics
Sep 08, 2021
Shareholder
Uninformative Sell
274.79K
$12.90M
Acutus Medical
Jul 21, 2021
Director, Ten Percent Owner
Informative Buy
15.00M
$65.57K
CalciMedica
Sep 29, 2020
Ten Percent Owner
Uninformative Buy
$17.36M
PMV Pharmaceuticals
Nov 24, 2023
Ten Percent Owner
Informative Sell
195.76K
$10.30M
Prelude Therapeutics
May 24, 2023
Director, Ten Percent Owner
Informative Buy
5.00M
$56.00M
Galecto
Aug 17, 2023
Ten Percent Owner
Informative Sell
617.01K
$874.51K
KNTE
Kinnate Biopharma
Apr 05, 2024
Uninformative Sell
$0.00
Terns Pharmaceuticals
Jul 17, 2024
Director, Ten Percent Owner
Informative Sell
561.64K
$6.57M
DBTX
Decibel Therapeutics
Feb 19, 2021
Uninformative Buy
$4.34M
Edgewise Therapeutics
Jan 25, 2024
Director, Ten Percent Owner
Informative Buy
5.00M
$307.66M
Ikena Oncology
Sep 14, 2023
Director
Uninformative Buy
$13.24M
NeuroPace
May 03, 2024
Ten Percent Owner
Informative Sell
409.43K
$24.87M
Janux Therapeutics Inc
Dec 30, 2021
Director
Informative Sell
820.12K
$9.95M
THRX
Theseus Pharmaceuticals
Feb 14, 2024
Uninformative Sell
$0.00
Compass Therapeutics
Nov 10, 2022
Director, Ten Percent Owner
Informative Buy
1.29M
$18.04M
Third Harmonic Bio, Inc.
Sep 21, 2022
Director, Ten Percent Owner
Uninformative Buy
$69.41M
Verona Pharma
May 15, 2023
Director
Informative Sell
9.94M
$85.30M
Disc Medicine
Jun 20, 2024
Director
Informative Buy
3.00M
$10.87M
Turnstone Biologics Corp.
Jul 24, 2023
Director, Ten Percent Owner
Informative Buy
5.00M
$7.35M
ARS Pharmaceuticals
Aug 31, 2023
Director
Informative Buy
3.10M
$96.52M
ArriVent BioPharma, Inc.
Jan 31, 2024
Director, Ten Percent Owner
Uninformative Buy
$29.06M
X4 Pharmaceuticals
Nov 20, 2017
Ten Percent Owner
Informative Buy
3.66M
$1.40M
scPharmaceuticals
Nov 29, 2022
Ten Percent Owner
Informative Buy
4.00M
$24.96M
Pieris Pharmaceuticals
May 02, 2018
See Remarks, Ten Percent Owner
Informative Sell
6.35M
$298.91K
Kala Pharmaceuticals
Feb 12, 2018
Ten Percent Owner
Informative Buy
323.25K
$23.55M
Synlogic
Apr 22, 2021
Director
Uninformative Buy
5.00M
$5.91M
ARMO
Armo Biosciences Inc
Jun 22, 2018
Uninformative Sell
205.95M
$205.86M
Adicet Bio
Jan 26, 2024
Director, Ten Percent Owner
Informative Buy
7.50M
$3.60M
~BOLD
Audentes Therapeutics
Mar 12, 2018
Informative Sell
5.47M
$212.29M
Corvus Pharmaceuticals
Sep 22, 2021
Director, Ten Percent Owner
Informative Sell
6.76M
$14.86M
Rhythm Pharmaceuticals
May 24, 2018
See Remarks, Ten Percent Owner
Informative Sell
595.77K
$135.47M
Aadi Bioscience
Jul 02, 2018
Director, Ten Percent Owner
Informative Buy
2.99M
$7.95M
CNST
Constellation Pharmaceuticals
Jul 24, 2018
Uninformative Buy
$14.21M
Xtant Medical Holdings
Aug 17, 2022
Director, Ten Percent Owner
Uninformative Buy
$160.27K
PRNB
Principia Biopharma
May 22, 2019
Informative Sell
30.25M
$160.65M
Guardant Health
Oct 11, 2018
Ten Percent Owner
Uninformative Buy
$279.48K
~LOGC
Logicbio Therapeutics
Oct 25, 2018
Uninformative Buy
$13.39M
Inspire Medical Systems
Aug 19, 2020
Director
Informative Sell
14.93M
$245.87K
~THOR
Thoratec Corp
Dec 13, 2018
Informative Buy
15.00M
$337.59M
Alector
Apr 16, 2020
Ten Percent Owner
Informative Sell
2.01M
$11.12M
~AVDR
Avedro
Feb 19, 2019
Uninformative Buy
$97.48M
TCDAQ
Tricida
Nov 25, 2022
Informative Sell
2.21M
$0.00
TPTX
Turning Point Therapeutics
Apr 24, 2019
Uninformative Buy
$154.11M
NextCure
May 13, 2019
Director, Ten Percent Owner
Informative Buy
5.25M
$4.55M
TELA Bio
Jul 02, 2024
Ten Percent Owner
Informative Sell
2.02M
$10.95M
89bio
Jan 27, 2022
Ten Percent Owner
Informative Sell
592.38K
$15.24M
Springworks Therapeutics
Sep 14, 2022
Ten Percent Owner
Informative Sell
4.92M
$204.17M
PRVL
Prevail Therapeutics
Jun 26, 2019
Informative Buy
15.00M
$317.92M
ALPN
Alpine Immune Sciences
May 20, 2024
Uninformative Sell
$0.00
SRRA
Sierra Oncology
Jul 01, 2022
Uninformative Sell
108.06M
$0.00
Arcutis Biotherapeutics
Jun 28, 2022
Ten Percent Owner
Informative Sell
7.29M
$4.06M
Passage Bio
Jun 29, 2023
Ten Percent Owner
Informative Buy
1.00M
$7.15M
Enliven Therapeutics
May 20, 2024
Director, Ten Percent Owner
Informative Sell
22.88M
$173.19M
Keros Therapeutics
Apr 13, 2020
Director
Informative Buy
6.00M
$53.77M
Oric Pharmaceuticals
Mar 31, 2021
Director
Uninformative Sell
2.43M
$22.61M
Adaptimmune Therapeutics
Jun 06, 2018
Director
Informative Sell
253.63K
$5.78M
Viewray
Aug 20, 2018
Ten Percent Owner
Informative Sell
5.19M
$835.40
Glaukos
Mar 06, 2018
Director
Informative Sell
26.79M
$0.00
STDY
Steadymed
Sep 07, 2018
Informative Sell
18.94M
$0.00
Nabriva Therapeutics
Dec 30, 2016
Director, Ten Percent Owner
Informative Buy
$50.95K
Spyre Therapeutics
Feb 21, 2017
Ten Percent Owner
Informative Buy
563.88K
$43.73M
RLYP
Relypsa Inc
Jul 26, 2016
Informative Sell
129.39M
$236.73M
MRTX
Mirati Therapeutics
Feb 05, 2015
Informative Buy
2.00M
$74.37M
SIENQ
Sientra
Oct 13, 2015
Informative Sell
1.72M
$427.50
Pacira Pharmaceuticals
Mar 13, 2012
Ten Percent Owner
Informative Sell
1.11M
$49.46M
Anthera Pharmaceuticals
Feb 01, 2013
Director
Informative Buy
3.76M
$223.86K
OTIC
Otonomy
Nov 30, 2015
Informative Sell
1.94M
$212.76K
Insulet
Director
$305.86M
NXTM
NxStage Medical
Dec 13, 2010
Informative Sell
53.25K
$80.71M
LOXO
Loxo Oncology
Dec 12, 2017
Informative Sell
20.63M
$220.82M
XLRN
Acceleron Pharma
Sep 26, 2013
Uninformative Buy
$103.12M
Supernus Pharmaceuticals
Feb 14, 2013
Ten Percent Owner
Informative Sell
2.28M
$23.77M
CCXI
ChemoCentryx
Feb 15, 2012
Uninformative Buy
$47.23M
ALBO
Albireo Pharma
Jun 11, 2009
Uninformative Sell
$65.60M
ROKA
Sorrento Tech Inc
Oct 05, 2017
Informative Sell
137.10K
$19.75K
Athersys
Apr 29, 2011
Ten Percent Owner
Informative Sell
551.98K
$152.50
Amarin
Sep 05, 2012
Director
Uninformative Sell
3.37M
$4.50K
AVNR
Avanir Pharmaceuticals
~GNOM
Complete Genomics
GIVN
Given Imaging Ltd
VOLC
Volcano Corp
~AMBI
Ambit
May 24, 2013
Informative Buy
233.37K
List of latest transactions for each holding click on a transaction to see Orbimed Advisors Llc's performance on stock

Orbimed Advisors Llc insider profile FAQ

What is the percentage of profitable transactions made by Orbimed Advisors Llc?
The percentage of profitable transactions made by Orbimed Advisors Llc is 56%.
    What is the average return per transaction made by Orbimed Advisors Llc?
    The average return per transaction made by Orbimed Advisors Llc is 4.80%.
      What stocks does Orbimed Advisors Llc hold?
      Orbimed Advisors Llc holds: CTIC, ICPT, RPTX, AFIB, CALC, PMVP, PRLD, GLTO, KNTE, TERN, DBTX, EWTX, IKNA, NPCE, JANX, THRX, CMPX, THRD, VRNA, IRON, TSBX, SPRY, AVBP, XFOR, SCPH, PIRS, KALA, SYBX, ARMO, ACET, ~BOLD, CRVS, RYTM, AADI, CNST, XTNT, PRNB, GH, ~LOGC, INSP, ~THOR, ALEC, ~AVDR, TCDAQ, TPTX, NXTC, TELA, ETNB, SWTX, PRVL, ALPN, SRRA, ARQT, PASG, ELVN, KROS, ORIC, ADAP, VRAYQ, GKOS, STDY, NBRVF, SYRE, RLYP, MRTX, SIENQ, PCRX, ANTH, OTIC, PODD, NXTM, LOXO, XLRN, SUPN, CCXI, ALBO, ROKA, ATHXQ, AMRN, AVNR, ~GNOM, GIVN, VOLC, ~AMBI stocks.
        What was Orbimed Advisors Llc’s latest transaction?
        Orbimed Advisors Llc latest transaction was an Informative Sell of $561.64K.
          What was Orbimed Advisors Llc's most profitable transaction?
          Orbimed Advisors Llc’s most profitable transaction was an Informative Buy of SIENQ stock on October 28, 2014. The return on the trade was 570.60%.
            What is Orbimed Advisors Llc's role in CTI BioPharma?
            Orbimed Advisors Llc's role in CTI BioPharma is Shareholder.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.